{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T01:20:15Z","timestamp":1778635215768,"version":"3.51.4"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,1,25]],"date-time":"2015-01-25T00:00:00Z","timestamp":1422144000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Amino Acids"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s00726-015-1915-3","type":"journal-article","created":{"date-parts":[[2015,1,24]],"date-time":"2015-01-24T09:34:08Z","timestamp":1422092048000},"page":"1885-1891","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Plasma homoarginine, arginine, asymmetric dimethylarginine and total homocysteine interrelationships in rheumatoid arthritis, coronary artery disease and peripheral artery occlusion disease"],"prefix":"10.1007","volume":"47","author":[{"given":"Arslan Arinc","family":"Kayacelebi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janina","family":"Willers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vu Vi","family":"Pham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica Y.","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Rothmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen C.","family":"Fr\u00f6lich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Tsikas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,25]]},"reference":[{"key":"1915_CR1","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/ajcn\/84.4.781","volume":"84","author":"C Antoniades","year":"2006","unstructured":"Antoniades C, Tousoulis D, Marinou K, Vasiliadou C, Tentolouris C, Bouras G, Pitsavos C, Stefanadis C (2006) Asymmetrical dimethylarginine regulates endothelial function in methionine-induced but not in chronic homocystinemia in humans: effect of oxidative stress and proinflammatory cytokines. Am J Clin Nutr 84:781\u2013788","journal-title":"Am J Clin Nutr"},{"key":"1915_CR2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.phrs.2009.07.001","volume":"60","author":"RH B\u00f6ger","year":"2009","unstructured":"B\u00f6ger RH, Maas R, Schulze F, Schwedhelm E (2009) Asymmetric dimethylarginine (ADMA) as a prospective marker of cardiovascular disease and mortality\u2014an update on patient populations with a wide range of cardiovascular risk. Pharmacol Res 60:481\u2013487","journal-title":"Pharmacol Res"},{"key":"1915_CR3","doi-asserted-by":"crossref","first-page":"46789","DOI":"10.1074\/jbc.M306787200","volume":"278","author":"LE Bretscher","year":"2003","unstructured":"Bretscher LE, Li H, Poulos TL, Griffith OW (2003) Structural characterization and kinetics of nitric-oxide synthase inhibition by novel N5-(iminoalkyl)- and N5-(iminoalkenyl)-ornithines. J Biol Chem 278:46789\u201346797","journal-title":"J Biol Chem"},{"key":"1915_CR4","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00726-011-0853-y","volume":"40","author":"JT Brosnan","year":"2011","unstructured":"Brosnan JT, da Silva RP, Brosnan ME (2011) The metabolic burden of creatine synthesis. Amino Acids 40:1325\u20131331","journal-title":"Amino Acids"},{"key":"1915_CR5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.niox.2011.08.003","volume":"25","author":"K Chobanyan-J\u00fcrgens","year":"2011","unstructured":"Chobanyan-J\u00fcrgens K, Pham VV, Stichtenoth DO, Tsikas D (2011) Elevated dimethylarginine dimethylaminohydrolase (DDAH) activity in rheumatoid arthritis and spondyloarthritis. Nitric Oxide 25:436\u2013438","journal-title":"Nitric Oxide"},{"key":"1915_CR6","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1161\/CIRCULATIONAHA.112.000580","volume":"128","author":"CU Choe","year":"2013","unstructured":"Choe CU, Atzler D, Wild PS, Carter AM, B\u00f6ger RH, Ojeda F, Simova O, Stockebrand M, Lackner K, Nabuurs C, Marescau B, Streichert T, Muller C, Luneburg N, De Deyn PP, Benndorf RA, Baldus S, Gerloff C, Blankenberg S, Heerschap A, Grant PJ, Magnus T, Zeller T, Isbrandt D, Schwedhelm E (2013) Homoarginine levels are regulated by l-arginine:glycine amidinotransferase and affect stroke outcome: results from human and murine studies. Circulation 128:1451\u20131461","journal-title":"Circulation"},{"key":"1915_CR7","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1002\/art.21349","volume":"52","author":"CS Crowson","year":"2005","unstructured":"Crowson CS, Nicola PJ, Kremers HM, O\u2019Fallon WM, Therneau TM, Jacobsen SJ, Roger VL, Ballman KV, Gabriel SE (2005) How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? Arthritis Rheum 52:3039\u20133044","journal-title":"Arthritis Rheum"},{"key":"1915_CR8","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1016\/j.febslet.2012.08.020","volume":"586","author":"M Davids","year":"2012","unstructured":"Davids M, Ndika JD, Salomons GS, Blom HJ, Teerlink T (2012) Promiscuous activity of arginine:glycine amidinotransferase is responsible for the synthesis of the novel cardiovascular risk factor homoarginine. FEBS Lett 586:3653\u20133657","journal-title":"FEBS Lett"},{"key":"1915_CR9","doi-asserted-by":"crossref","first-page":"12315","DOI":"10.3390\/ijms131012315","volume":"13","author":"T Dimitroulas","year":"2012","unstructured":"Dimitroulas T, Sandoo A, Kitas GD (2012) Asymmetric dimethylarginine as a surrogate marker of endothelial dysfunction and cardiovascular risk in patients with systemic rheumatic diseases. Int J Mol Sci 13:12315\u201312335","journal-title":"Int J Mol Sci"},{"key":"1915_CR10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3109\/03009742.2012.747627","volume":"42","author":"T Dimitroulas","year":"2013","unstructured":"Dimitroulas T, Sandoo A, van Veldhuijzen JJZ et al (2013) Predictors of asymmetric dimethylarginine levels in patients with rheumatoid arthritis: the role of insulin resistance. Scand J Rheumatol 42:176\u2013181","journal-title":"Scand J Rheumatol"},{"key":"1915_CR11","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijcard.2013.12.235","volume":"172","author":"T Dimitroulas","year":"2014","unstructured":"Dimitroulas T, Sandoo A, Smith JP, Kitas GD (2014) Asymmetric dimethylarginine is not associated with subendocardial viability ratio in rheumatoid arthritis. Int J Cardiol 172:285\u2013286","journal-title":"Int J Cardiol"},{"issue":"3","key":"1915_CR12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.metabol.2004.09.015","volume":"54","author":"S Doshi","year":"2005","unstructured":"Doshi S, McDowell I, Goodfellow J, Stabler S, Boger R, Allen R, Newcombe R, Lewis M, Moat S (2005) Relationship between S-adenosylmethionine, S-adenosylhomocysteine, asymmetric dimethylarginine, and endothelial function in healthy human subjects during experimental hyper- and hypohomocysteinemia. Metabolism 54(3):351\u2013360","journal-title":"Metabolism"},{"key":"1915_CR13","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/eurjhf\/hfr056","volume":"13","author":"C Drechsler","year":"2011","unstructured":"Drechsler C, Meinitzer A, Pilz S, Krane V, Tomaschitz A, Ritz E, M\u00e4rz W, Wanner C (2011) Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients. Eur J Heart Fail 13:852\u2013859","journal-title":"Eur J Heart Fail"},{"key":"1915_CR14","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/10408360903142326","volume":"46","author":"D Giustarini","year":"2009","unstructured":"Giustarini D, Dalle-Donne I, Tsikas D, Rossi R (2009) Oxidative stress and human diseases: origin, link, measurement, mechanisms, and biomarkers. Crit Rev Clin Lab Sci 46:241\u2013281","journal-title":"Crit Rev Clin Lab Sci"},{"key":"1915_CR15","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jchromb.2006.09.023","volume":"851","author":"JD Horowitz","year":"2007","unstructured":"Horowitz JD, Heresztyn T (2007) An overview of plasma concentrations of asymmetric dimethylarginine (ADMA) in health and disease and in clinical studies: methodological considerations. J Chromatogr B 851:42\u201350","journal-title":"J Chromatogr B"},{"key":"1915_CR16","doi-asserted-by":"crossref","first-page":"21819","DOI":"10.3390\/ijms141121819","volume":"14","author":"A Ja\u017awi\u0144ska-Kozuba","year":"2013","unstructured":"Ja\u017awi\u0144ska-Kozuba A, Martens-Lobenhoffer J, Kruszelnicka O, Rycaj J, Chyrchel B, Surdacki A, Bode-B\u00f6ger SM (2013) Opposite associations of plasma homoarginine and ornithine with arginine in healthy children and adolescents. Int J Mol Sci 14:21819\u201321832","journal-title":"Int J Mol Sci"},{"key":"1915_CR17","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1007\/s00726-014-1774-3","volume":"46","author":"AA Kayacelebi","year":"2014","unstructured":"Kayacelebi AA, Beckmann B, Gutzki FM, Jordan J, Tsikas D (2014a) GC-MS and GC-MS\/MS measurement of the cardiovascular risk factor homoarginine in biological samples. Amino Acids 46:2205\u20132217","journal-title":"Amino Acids"},{"key":"1915_CR18","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.ijcard.2014.03.080","volume":"173","author":"AA Kayacelebi","year":"2014","unstructured":"Kayacelebi AA, Nguyen TH, Neil C, Horowitz JD, Jordan J, Tsikas D (2014b) Homoarginine and 3-nitrotyrosine in patients with takotsubo cardiomyopathy. Int J Cardiol 173:546\u2013547","journal-title":"Int J Cardiol"},{"key":"1915_CR19","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.ijcard.2014.07.296","volume":"176","author":"AA Kayacelebi","year":"2014","unstructured":"Kayacelebi AA, Pham VV, Willers J, Hahn A, Stichtenoth DO, Jordan J, Tsikas D (2014c) Plasma homoarginine (hArg) and asymmetric dimethylarginine (ADMA) in patients with rheumatoid arthritis: is homoarginine a cardiovascular corrective in rheumatoid arthritis, an anti-ADMA? Int J Cardiol 176:1129\u20131131","journal-title":"Int J Cardiol"},{"key":"1915_CR20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/jhh.2011.109","volume":"27","author":"AA Khalil","year":"2013","unstructured":"Khalil AA, Tsikas D, Akolekar R, Jordan J, Nicolaides KH (2013) Asymmetric dimethylarginine, arginine and homoarginine at 11\u201313 weeks\u2019 gestation and preeclampsia: a case-control study. J Hum Hypertens 27:38\u201343","journal-title":"J Hum Hypertens"},{"key":"1915_CR21","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0008-6363(99)00162-5","volume":"43","author":"J Leiper","year":"1999","unstructured":"Leiper J, Vallance P (1999) Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc Res 43:542\u2013548","journal-title":"Cardiovasc Res"},{"key":"1915_CR22","first-page":"673","volume":"26","author":"L L\u00e9vy","year":"2008","unstructured":"L\u00e9vy L, Fautrel B, Barnetche T, Schaeverbeke T (2008) Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature. Clin Exp Rheumatol 26:673\u2013679","journal-title":"Clin Exp Rheumatol"},{"key":"1915_CR23","doi-asserted-by":"crossref","unstructured":"Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest J (2006) Heart outcomes prevention evaluation (HOPE) 2 investigators homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354: 1567\u20131577","DOI":"10.1056\/NEJMoa060900"},{"key":"1915_CR24","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/CIRCULATIONAHA.109.908988","volume":"122","author":"W M\u00e4rz","year":"2010","unstructured":"M\u00e4rz W, Meinitzer A, Drechsler C, Pilz S, Krane V, Kleber ME, Fischer J, Winkelmann BR, B\u00f6hm BO, Ritz E, Wanner C (2010) Homoarginine, cardiovascular risk, and mortality. Circulation 122:967\u2013975","journal-title":"Circulation"},{"key":"1915_CR25","doi-asserted-by":"crossref","first-page":"10453","DOI":"10.1021\/bi980742t","volume":"37","author":"C Moali","year":"1998","unstructured":"Moali C, Boucher JL, Sari MA, Stuehr DJ, Mansuy D (1998) Substrate specificity of NO synthases: detailed comparison of l-arginine, homo-l-arginine, their N omega-hydroxy derivatives, and N omega-hydroxynor-l-arginine. Biochemistry 37:10453\u201310460","journal-title":"Biochemistry"},{"key":"1915_CR26","doi-asserted-by":"crossref","first-page":"8208","DOI":"10.1021\/bi992992v","volume":"39","author":"C Moali","year":"2000","unstructured":"Moali C, Brollo M, Custot J, Sari MA, Boucher JL, Stuehr DJ, Mansuy D (2000) Recognition of alpha-amino acids bearing various C\u00a0=\u00a0NOH functions by nitric oxide synthase and arginase involves very different structural determinants. Biochemistry 39:8208\u20138218","journal-title":"Biochemistry"},{"key":"1915_CR27","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJM199312303292706","volume":"329","author":"S Moncada","year":"1993","unstructured":"Moncada S, Higgs A (1993) The l-arginine-nitric oxide pathway. New Engl J Med 329:2002\u20132012","journal-title":"New Engl J Med"},{"key":"1915_CR28","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/ajcn\/85.1.19","volume":"85","author":"SH Mudd","year":"2007","unstructured":"Mudd SH, Brosnan JT, Brosnan ME, Jacobs RL, Stabler SP, Allen RH, Vance DE, Wagner C (2007) Methyl balance and transmethylation fluxes in humans. Am J Clin Nutr 85:19\u201325","journal-title":"Am J Clin Nutr"},{"issue":"4","key":"1915_CR29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00726-005-0191-z","volume":"28","author":"R Paroni","year":"2005","unstructured":"Paroni R, Fermo I, Fiorina P, Cighetti G (2005) Determination of asymmetric and symmetric dimethylarginines in plasma of hyperhomocysteinemic subjects. Amino Acids 28(4):389\u2013394","journal-title":"Amino Acids"},{"issue":"62","key":"1915_CR30","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/art.27392","volume":"2010","author":"M Perna","year":"2010","unstructured":"Perna M, Roman MJ, Alpert DR, Crow MK, Lockshin MD, Sammaritano L, Devereux RB, Cooke JP, Salmon JE (2010) Relationship of asymmetric dimethylarginine and homocysteine to vascular aging in systemic lupus erythematosus patients. Arthritis Rheum 2010(62):1718\u20131722","journal-title":"Arthritis Rheum"},{"key":"1915_CR31","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1161\/STROKEAHA.110.603035","volume":"42","author":"S Pilz","year":"2011","unstructured":"Pilz S, Tomaschitz A, Meinitzer A, Drechsler C, Ritz E, Krane V, Wanner C, Bohm BO, M\u00e4rz W (2011) Low serum homoarginine is a novel risk factor for fatal strokes in patients undergoing coronary angiography. Stroke 42:1132\u20131134","journal-title":"Stroke"},{"key":"1915_CR32","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/art.1780400418","volume":"40","author":"R Roubenoff","year":"1997","unstructured":"Roubenoff R, Dellaripa P, Nadeau MR, Abad LW, Muldoon BA, Selhub J, Rosenberg IH (1997) Abnormal homocysteine metabolism in rheumatoid arthritis. Arthritis Rheum 40:718\u2013722","journal-title":"Arthritis Rheum"},{"key":"1915_CR33","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1126\/science.144.3622.1122","volume":"144","author":"WL Ryan","year":"1964","unstructured":"Ryan WL, Wells IC (1964) Homocitrulline and homoarginine synthesis from lysine. Science 144:1122\u20131127","journal-title":"Science"},{"key":"1915_CR34","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0003-9861(69)90425-1","volume":"131","author":"WL Ryan","year":"1969","unstructured":"Ryan WL, Johnson RJ, Dimari S (1969) Homoarginine synthesis by rat kidney. Arch Biochem Biophys 131:521\u2013526","journal-title":"Arch Biochem Biophys"},{"key":"1915_CR35","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1253\/circj.CJ-13-1334","volume":"78","author":"A Sobczak","year":"2014","unstructured":"Sobczak A, Prokopowicz A, Radek M, Szula M, Zaciera M, Kurek J, Goniewicz ML (2014) Tobacco smoking decreases plasma concentration of the emerging cardiovascular risk marker, l-homoarginine. Circ J 78:1254\u20131258","journal-title":"Circ J"},{"key":"1915_CR36","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/01.CIR.0000085067.55901.89","volume":"108","author":"MC St\u00fchlinger","year":"2003","unstructured":"St\u00fchlinger MC, Oka RK, Graf EE, Schm\u00f6lzer I, Upson BM, Kapoor O, Szuba A, Malinow MR, Wascher TC, Pachinger O, Cooke JP (2003) Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine. Circulation 108:933\u2013938","journal-title":"Circulation"},{"key":"1915_CR37","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/art.22424","volume":"56","author":"A Surdacki","year":"2007","unstructured":"Surdacki A, Martens-Lobenhoffer J, Wloch A et al (2007) Elevated plasma asymmetric dimethyl-l-arginine levels are linked to endothelial progenitor cell depletion and carotid atherosclerosis in rheumatoid arthritis. Arthritis Rheum 56:809\u2013819","journal-title":"Arthritis Rheum"},{"key":"1915_CR38","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ab.2008.04.018","volume":"379","author":"D Tsikas","year":"2008","unstructured":"Tsikas D (2008) A critical review and discussion of analytical methods in the l-arginine\/nitric oxide area of basic and clinical research. Anal Biochem 379:139\u2013163","journal-title":"Anal Biochem"},{"key":"1915_CR39","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1253\/circj.CJ-14-0484","volume":"78","author":"D Tsikas","year":"2014","unstructured":"Tsikas D, Kayacelebi AA (2014) Do homoarginine and asymmetric dimethylarginine act antagonistically in the cardiovascular system? Circ J 78:2094\u20132095","journal-title":"Circ J"},{"key":"1915_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-5793(00)01686-0","volume":"478","author":"D Tsikas","year":"2000","unstructured":"Tsikas D, B\u00f6ger RH, Sandmann J, Bode-B\u00f6ger SM, Fr\u00f6lich JC (2000) Endogenous nitric oxide synthase inhibitors are responsible for the l-arginine paradox. FEBS Lett 478:1\u20133","journal-title":"FEBS Lett"},{"key":"1915_CR41","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jchromb.2003.09.001","volume":"798","author":"D Tsikas","year":"2003","unstructured":"Tsikas D, Schubert B, Gutzki FM, Sandmann J, Fr\u00f6lich JC (2003) Quantitative determination of circulating and urinary asymmetric dimethylarginine (ADMA) in humans by gas chromatography-tandem mass spectrometry as methyl ester tri(N-pentafluoropropionyl) derivative. J Chromatogr B 798:87\u201399","journal-title":"J Chromatogr B"},{"key":"1915_CR42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jchromb.2006.09.015","volume":"851","author":"D Tsikas","year":"2007","unstructured":"Tsikas D, Thum T, Becker T, Pham VV, Chobanyan K, Mitschke A, Beckmann B, Gutzki FM, Bauersachs J, Stichtenoth DO (2007) Accurate quantification of dimethylamine (DMA) in human urine by gas chromatography-mass spectrometry as pentafluorobenzamide derivative: evaluation of the relationship between DMA and its precursor asymmetric dimethylarginine (ADMA) in health and disease. J Chromatogr B 851:229\u2013239","journal-title":"J Chromatogr B"},{"key":"1915_CR43","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1253\/circj.CJ-08-0240","volume":"72","author":"P Valtonen","year":"2008","unstructured":"Valtonen P, Laitinen T, Lyyra-Laitinen T, Raitakari OT, Juonala M, Viikari JS, Heiskanen N, Vanninen E, Punnonen K, Heinonen S (2008) Serum l-homoarginine concentration is elevated during normal pregnancy and is related to flow-mediated vasodilatation. Circ J 72:1879\u20131884","journal-title":"Circ J"},{"key":"1915_CR44","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1097\/HJH.0b013e32836037fb","volume":"31","author":"LP Zwan van der","year":"2013","unstructured":"van der Zwan LP, Davids M, Scheffer PG, Dekker JM, Stehouver CDA, Teerlink T (2013) l-Homoarginine and arginine are antagonistically related to blood pressure in an elderly population: the Hoorn study. J Hypertens 31:1114\u20131123","journal-title":"J Hypertens"},{"key":"1915_CR45","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1080\/00365510310002040","volume":"63","author":"P Wanby","year":"2003","unstructured":"Wanby P, Brattstr\u00f6m L, Brudin L, Hultberg B, Teerlink T (2003) Asymmetric dimethylarginine and total homocysteine in plasma after oral methionine loading. Scand J Clin Lab Invest 63:347\u2013353","journal-title":"Scand J Clin Lab Invest"},{"key":"1915_CR46","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.atherosclerosis.2005.05.002","volume":"184","author":"J Wang","year":"2006","unstructured":"Wang J, Sim AS, Wang XL, Salonikas C, Naidoo D, Wilcken DE (2006) Relations between plasma asymmetric dimethylarginine (ADMA) and risk factors for coronary disease. Atherosclerosis 184:383\u2013388","journal-title":"Atherosclerosis"},{"key":"1915_CR47","doi-asserted-by":"crossref","first-page":"3741","DOI":"10.1007\/s00296-011-2238-7","volume":"32","author":"J Willers","year":"2012","unstructured":"Willers J, Hahn A (2012) Cardiovascular risk in patients with rheumatoid arthritis: assessment of several traditional risk parameters and of a German risk score model. Rheumatol Int 32:3741\u20133749","journal-title":"Rheumatol Int"},{"key":"1915_CR48","doi-asserted-by":"crossref","first-page":"714","DOI":"10.4236\/fns.2011.27098","volume":"2","author":"J Willers","year":"2011","unstructured":"Willers J, Fasse S, Putschky N et al (2011) Combined add-on supplementation of omega-3 fatty acids, vitamin E, vitamin A, copper, and selenium in rheumatoid arthritis. Food Nutr Sci 2:714\u2013723","journal-title":"Food Nutr Sci"},{"key":"1915_CR49","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.hfc.2013.10.003","volume":"10","author":"K Wright","year":"2014","unstructured":"Wright K, Crowson CS, Gabriel SE (2014) Cardiovascular comorbidity in rheumatic diseases: a focus on heart failure. Heart Fail Clin 10:339\u2013352","journal-title":"Heart Fail Clin"},{"key":"1915_CR50","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00726-008-0210-y","volume":"37","author":"G Wu","year":"2009","unstructured":"Wu G, Bazer FW, Davis TA, Kim SW, Li P, Marc Rhoads J, Carey Satterfield M, Smith SB, Spencer TE, Yin Y (2009) Arginine metabolism and nutrition in growth, health and disease. Amino Acids 37:153\u2013168","journal-title":"Amino Acids"},{"key":"1915_CR51","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0021-9150(01)00444-0","volume":"158","author":"JH Yoo","year":"2001","unstructured":"Yoo JH, Lee SC (2001) Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke. Atherosclerosis 158:425\u2013430","journal-title":"Atherosclerosis"}],"container-title":["Amino Acids"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-015-1915-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00726-015-1915-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00726-015-1915-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T23:38:56Z","timestamp":1566257936000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00726-015-1915-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,25]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["1915"],"URL":"https:\/\/doi.org\/10.1007\/s00726-015-1915-3","relation":{},"ISSN":["0939-4451","1438-2199"],"issn-type":[{"value":"0939-4451","type":"print"},{"value":"1438-2199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,25]]}}}